A Novel Mutation in CRYGC Mutation Associated with Autosomal Dominant Congenital Cataracts and Microcornea

Zhenbao Zhou, MD; Liying Zhao, MD; Yanqin Guo, MD; Jingyi Zhuang, MD; Nan Zhuo, MD; Han Chen, MD; Jieting Liu, MD; Libo Wang, MD

Ophthalmology Science (Mar 2022)

A Novel Mutation in CRYGC Mutation Associated with Autosomal Dominant Congenital Cataracts and Microcornea

Zhenbao Zhou, MD,
Liying Zhao, MD,
Yanqin Guo, MD,
Jingyi Zhuang, MD,
Nan Zhuo, MD,
Han Chen, MD,
Jieting Liu, MD,
Libo Wang, MD

Affiliations

Zhenbao Zhou, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Ophthalmology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China; Department of Neurology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China
Liying Zhao, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Ophthalmology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China; Department of Neurology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China; Correspondence: Liying Zhao, MD, Department of Ophthalmology, HongQi Hospital, MuDanJiang Medical University, No. 3, Tongxiang St., Aimin District, Mudanjiang City, Heilongjiang 157000, China.
Yanqin Guo, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Ophthalmology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China; Department of Neurology, HongQi Hospital, Mudanjiang Medical University, Mudanjiang, China
Jingyi Zhuang, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Biomedical Engineering, Mudanjiang Medical University, Mudanjiang, China
Nan Zhuo, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Biomedical Engineering, Mudanjiang Medical University, Mudanjiang, China
Han Chen, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Biomedical Engineering, Mudanjiang Medical University, Mudanjiang, China
Jieting Liu, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China; Department of Biomedical Engineering, Mudanjiang Medical University, Mudanjiang, China
Libo Wang, MD: Department of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China

Journal volume & issue: Vol. 2, no. 1
p. 100093

Abstract

Read online

Purpose: Crystallin protein mutations are associated with congenital cataract (CC), and several disease-causing mutations in the CRYGC gene have been identified. We present the location of a new mutation in CRYGC in members of a Chinese family who presented with CCs with or without microcornea. Design: Observational study. Participants: A Chinese family diagnosed with autosomal dominant (AD) CCs with or without microphthalmia. Methods: Because this was an observational study, it was not registered as a clinical trial. The proband and her 2 children were diagnosed with AD CCs and microcornea and were recruited for the study. Participants underwent complete ophthalmological examinations, and blood samples were used for genomic extraction. Main Outcome Measures: We detected 1 disease-associated variant using Exomiser analysis by matching the proband’s phenotype and the inheritance pattern. The variant was determined to be pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines. Results: We detected 1 disease-associated variant using Exomiser analysis by matching the proband’s phenotype and the inheritance pattern. The variant was determined to be pathogenic according to the American College of Medical Genetics and Genomics guidelines. Next-generation sequencing was verified using Sanger sequencing, and we confirmed that the proband and her children carried the same mutation. We identified the heterozygous variant c.389_390insGCTG (p.C130fs), which includes a frameshift mutation. The residues in p.C130fs are all highly conserved across species. This disease-causing frameshift mutation in the CRYGC gene is not currently present in the ClinVar database. Conclusions: Our findings expand the repertoire of known mutations in the CRYGC gene that cause CCs and provide new insights into the etiology and molecular diagnosis of CCs; however, the molecular mechanism of this mutation warrants further investigation.

Published in Ophthalmology Science

ISSN: 2666-9145 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Ophthalmology
Website: https://www.journals.elsevier.com/ophthalmology-science/

About the journal

Abstract

Keywords